Press Releases - News for BioHouston

The top 50 press releases in our database are displayed below.

49 Record(s) Found. Displaying Page 1:

1 2 3 [Next >>]

DPT Laboratories creates manufacturing centers of excellence
Release Date: 19-Mar-10 Author or Contact:
DPT Laboratories Ltd. implemented a restructuring of the company’s manufacturing and pharmaceutical contract development operations to establish three new centers of excellence that will focus on different areas of expertise. San Antonio-based DPT set up its Center for Sterile & Specialty Products in Lakewood, N.J. This center will specialize in the development and aseptic manufacturing of clinical trial material and commercial scale ...
Click to read DPT Laboratories creates manufacturing centers of excellence

KCI launches new wound-care product in Canada, Europe
Release Date: 19-Mar-10 Author or Contact:
Kinetic Concepts Inc. (KCI) has rolled out a new wound-management system in the European and Canadian markets. San Antonio-based KCI (NYSE: KCI) has developed the Prevena Incision Management System, a medical device that relies on negative pressure to heal wounds following surgically closed incisions. Pre-market studies have shown that Prevena may reduce the risk of post-operative complications, such as infections. The product is now ...
Click to read KCI launches new wound-care product in Canada, Europe

CardioSpectra founders win UT System Chancellor’s award for entrepreneurship
Release Date: 17-Mar-10 Author or Contact:
University of Texas System Chancellor Francisco Cigarroa honored three professors within the system — including one in San Antonio — with the 2010 Chancellor’s Entrepreneurship and Innovation Award. Dr. Marc Feldman, associate professor of medicine and engineering at the University of Texas Health Science Center at San Antonio, was one of three professors within the UT System to receive the award. He and Tom Milner, the ...
Click to read CardioSpectra founders win UT System Chancellor’s award for entrepreneurship

Spinal Restoration closes $20M financing round
Release Date: 17-Mar-10 Author or Contact:
Medical research firm Spinal Restoration Inc. has completed a $20 million round of financing. Austin-based Spinal Restoration received the funding from four investors, according to a filing today with the U.S. Securities and Exchange Commission. The company, founded in 2004, develops therapies designed to address unmet needs in spine health management. In December 2009, Spinal Restoration revealed that it was beginning the third testing phase ...
Click to read Spinal Restoration closes $20M financing round

ArthoCare reports $34M loss '09, better Q4
Release Date: 16-Mar-10 Author or Contact:
Medical device maker ArthoCare Corp. improved financial performance overall last year, particularly in the fourth quarter, but still reported a $33.8 million net loss for the 2009 fiscal year. The company (Nasdaq: ARTC) manufactures minimally-invasive surgical devices for procedures such as repairing damaged shoulders and knees. ArthoCare moved to its headquarters to Central Texas in 2005, when it employed about 1,000 worldwide. ArthoCare's ...
Click to read ArthoCare reports $34M loss '09, better Q4

Vivante GMP Solutions Completes Successful QP Audit of GMP Facility and Quality Systems
Release Date: 11-Mar-10 Author or Contact:
Vivante GMP Solutions, Inc. ("Vivante"; www.vivante-gmp.com) today announced that it has successfully completed a "QP audit" of its manufacturing facility and quality systems. The audit was performed by a Qualified Person (QP) on behalf of a Vivante client, in anticipation of that client’s use of a biological vaccine product manufactured by Vivante in Phase I clinical trials within the European Union. Importantly, there were no major ...
Click to read Vivante GMP Solutions Completes Successful QP Audit of GMP Facility and Quality Systems

Jury rules in favor of KCI in Smith & Nephew patent dispute
Release Date: 10-Mar-10 Author or Contact:
A San Antonio jury has found that a negative pressure wound-therapy product marketed and sold by Smith & Nephew infringes on two patents owned by Wake Forest University Health Sciences and licensed to Kinetic Concepts Inc. The jury held that each of the patents in the case are valid and KCI and Wake Forest are entitled to damages. KCI will be seeking an injunction in post-trial proceedings in the U.S. District Court in San Antonio against ...
Click to read Jury rules in favor of KCI in Smith & Nephew patent dispute

Ascension Orthopedics Introduces the PyroTITAN(TM) Humeral Resurfacing Arthroplasty System
Release Date: 10-Mar-10 Author or Contact: Laura Latimer
AUSTIN, Texas, March 8 /PRNewswire/ -- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the international market launch of the PyroTITAN(TM) Humeral Resurfacing Arthroplasty System at the American Academy of Orthopaedic Surgeons Annual Conference in New Orleans, LA, March 9-13, 2010. Designed to meet the unique soft tissue biocompatibility requirements of the shoulder joint, the PyroTITAN humeral resurfacing ...
Click to read Ascension Orthopedics Introduces the PyroTITAN(TM) Humeral Resurfacing Arthroplasty System

VGXI Expands Manufacturing Facility, Adds Key Personnel
Release Date: 9-Mar-10 Author or Contact: David Colvin
NEW ORLEANS--(BUSINESS WIRE)--Mar 4, 2010 - VGXI, Inc., a leading provider of DNA plasmid manufacturing and development services, announced today at the 2010 DNA Vaccines Conference the expansion of its state-of-the-art cGMP plasmid manufacturing facility in The Woodlands, TX. "This expansion nearly doubles the size of our current facility putting us in a much better position to meet the growing demand for our research and cGMP manufacturing ...
Click to read VGXI Expands Manufacturing Facility, Adds Key Personnel

Lexicon to put $95M in shares on sales block
Release Date: 8-Mar-10 Author or Contact:
Lexicon Pharmaceuticals Inc.'s shares slid 9 percent Monday after the biopharmaceutical firm announced plans to offer $95 million of its stock to the public. Lexicon (NASDAQ: LXRX) has granted underwriters up to $14.25 million in shares to cover any over-allotments. The Woodlands company’s shares closed March 5 at $1.78 per share. It has 175.7 million shares outstanding. Morgan Stanley & Co. Inc. and J.P. Morgan Securities Inc. will ...
Click to read Lexicon to put $95M in shares on sales block

UTSA opens New Venture Incubator on campus
Release Date: 8-Mar-10 Author or Contact:
The University of Texas at San Antonio has opened a new facility on campus that will offer office and laboratory space to technology entrepreneurs as a way to help them grow their companies. The UTSA Center for Innovation and Technology Entrepreneurship opened up the New Venture Incubator as part of its ongoing efforts to foster the development of more home-grown tech firms. The New Venture Incubator is located on UTSA’s Main Campus and ...
Click to read UTSA opens New Venture Incubator on campus

KCI gains approval to expand to Japanese wound-care market
Release Date: 8-Mar-10 Author or Contact:
Japanese health insurance regulators have approved Kinetic Concepts Inc.’s wound-care system for reimbursement. Japanese physicians who prescribe the company’s V.A.C. Therapy System, will be able to get reimbursed by the government. This move by the government clears the way for Kinetic Concepts (KCI) to have its products sold in Japan. With this approval in hand from Japan’s Health Insurance Bureau, KCI expects to begin ...
Click to read KCI gains approval to expand to Japanese wound-care market

Stem Cell Innovations to Provide Research and Assay Services to Agennix Read more: http://www.fiercebiotech.com/press-releases/stem-cell-innovations-provide-research-and-assay-services-agennix-0#ixzz
Release Date: 3-Mar-10 Author or Contact:
HOUSTON, March 2 /PRNewswire-FirstCall/ -- Stem Cell Innovations (Pink Sheets: SCLL) announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line. "We are happy to enter into this contract with Agennix," said James H. Kelly, PhD, CEO of Stem Cell Innovations. "Our C3A cells provide a reliable and ...
Click to read Stem Cell Innovations to Provide Research and Assay Services to Agennix Read more: http://www.fiercebiotech.com/press-releases/stem-cell-innovations-provide-research-and-assay-services-agennix-0#ixzz

Vidacare unveils bone marrow extraction device in U.S.
Release Date: 3-Mar-10 Author or Contact:
Vidacare Corp. has released its OnControl Bone Marrow System. The company developed this system with an eye toward raising the standard of care for bone marrow patients, while alleviating much of the pain of traditional procedures. Vidacare officials developed its system using its patented lithium battery-power driver. The OnControl Bone Marrow System is designed to quickly drill a needle directly into the marrow of a patient and ...
Click to read Vidacare unveils bone marrow extraction device in U.S.

Mission Pharmacal rolls out new product to help alleviate morning sickness
Release Date: 1-Mar-10 Author or Contact:
Mission Pharmacal Co. has developed a new vitamin supplement designed to help reduce the amount of morning sickness women face during pregnancy. The San Antonio company created a new B6-rich prescription prenatal vitamin, called CitraNatal B-Calm. It’s designed to boost a woman’s defense system against pregnancy-related nausea and vomiting. The scientific literature from the American College of Obstetricians and Gynecologists ...
Click to read Mission Pharmacal rolls out new product to help alleviate morning sickness

A&M gets big grant to make tobacco-based vaccine
Release Date: 24-Feb-10 Author or Contact:
The Texas A&M University System and a Texas company have been awarded a $40 million U.S. Department of Defense grant to develop vaccines made from tobacco, a hoped-for improvement on the antiquated egg-based technology that made the response to last year's swine flu outbreak so slow. The so-called Texas Plant-Expressed Vaccine Consortium announced the manufacturing initiative Wednesday. It will be headquartered in a 145,000-square-foot facility ...
Click to read A&M gets big grant to make tobacco-based vaccine

MicroTransponder Inc. raises $7M
Release Date: 24-Feb-10 Author or Contact:
Medical device developer MicroTransponder Inc. raised $7 million Series B round financing for its next clinical trial, according to a press release today. The Austin company is testing a wireless neurostimulation platform that will treat chronic pain and other neurological indications. MicroTransponder did not name the investors, but said the latest contribution came from existing funders and angel investors. At the same time, the ...
Click to read MicroTransponder Inc. raises $7M

Cyberonics approves share buyback program
Release Date: 18-Feb-10 Author or Contact:
The board of Cyberonics Inc. has approved a new share repurchase program of up to 1 million shares. This replaces an older buyback program of 1 million shares. The Houston medical technology company repurchased 515,000 shares under the program. Cyberonics (NASDAQ: CYBX) expects to complete this program by the end of fiscal 2011. The company has about 27.7 million shares outstanding.
Click to read Cyberonics approves share buyback program

Mission Pharmacal retools kidney stone drug
Release Date: 17-Feb-10 Author or Contact:
Mission Pharmacal Co. has developed a new formulation of its drug compound for kidney stone treatment. The San Antonio company’s new Urocit-K 15 mEq extended-release tablet has been developed with a maximum-strength alkalinizing agent that has been shown to help prevent kidney stone recurrence in more than 90 percent of patients. “The availability of Urocit-K 15 mEq is important for kidney stone patients because it can help ease ...
Click to read Mission Pharmacal retools kidney stone drug

Stematix inks deal with Argentine firm
Release Date: 15-Feb-10 Author or Contact:
Stematix Inc. has signed a 10-year agreement with Laboratorios Bagó to distribute certain Stematix products. Financial terms of the deal were not disclosed, however Houston-based Stematix has the option of additional forms of joint collaboration in clinical trials and treatments with Laboratorios Bagó, a medical products company based in Buenos Aires, Argentina. As part of the deal, Laboratorios Bagó will distribute a variety ...
Click to read Stematix inks deal with Argentine firm

1 2 3 [Next >>]

Contact Us | Site Map |

| OPML | Search This Site | Home
Schipul Web Design | Houston Social Media | Tendenci® Content Management Software | Privacy | Terms and Conditions